Daniela Paclik

Dr. Daniela Paclik

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Cellular Immunology
Verified
Journal Article
Closed access
DPDaniela Paclik
Daniela Paclik
LWLael Werner
Lael Werner
OGOlaf Guckelberger
Olaf Guckelberger
BWBertram Wiedenmann
Bertram Wiedenmann
ASAndreas Sturm
Andreas Sturm

12 July 2022 in Frontiers in Physiology
Verified
Journal Article
Open access
LGLaura Golusda
Laura Golusda
AKAnja A. Kühl
Anja A. Kühl
MLMalte Lehmann
Malte Lehmann
KDKatja Dahlke
Katja Dahlke
SMSusanne Mueller
Susanne Mueller
DPDaniela Paclik
Daniela Paclik
Inflammatory bowel diseases (IBD) comprise mainly ulcerative colitis (UC) and Crohn´s disease (CD). Both forms present with a chronic inflammation of the (gastro) intestinal tract, which induces excessive changes in the composition of the associated extracellular matrix (ECM). In UC, the inflammation is limited to the colon, whereas it can occur throughout the entire gastrointestinal tract in CD. Tools for early diagnosis of IBD are still very limited and highly invasive and measures for standardized evaluation of structural changes are scarce. To investigate an efficient non-invasive way of diagnosing intestinal inflammation and early changes of the ECM, very small superparamagnetic iron oxide nanoparticles (VSOPs) in magnetic resonance imaging (MRI) were applied in two mouse models of experimental colitis: the dextran sulfate sodium (DSS)-induced colitis and the transfer model of colitis. For further validation of ECM changes and inflammation, tissue sections were analyzed by immunohistochemistry. For in depth ex-vivo investigation of VSOPs localization within the tissue, Europium-doped VSOPs served to visualize the contrast agent by imaging mass cytometry (IMC). VSOPs accumulation in the inflamed colon wall of DSS-induced colitis mice was visualized in T2* weighted MRI scans. Components of the ECM, especially the hyaluronic acid content, were found to influence VSOPs binding. Using IMC, co-localization of VSOPs with macrophages and endothelial cells in colon tissue was shown. In contrast to the DSS model, colonic inflammation could not be visualized with VSOP-enhanced MRI in transfer colitis. VSOPs present a potential contrast agent for contrast-enhanced MRI to detect intestinal inflammation in mice at an early stage and in a less invasive manner depending on hyaluronic acid content.

6 December 2021 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
LGLaura Golusda
Laura Golusda
AKAnja A Kühl
Anja A Kühl
BSBritta Siegmund
Britta Siegmund
DPDaniela Paclik
Daniela Paclik
The incidence of inflammatory bowel disease with its two main manifestations, colitis ulcerosa and Crohn’s disease, is rising globally year after year. There is still a tremendous need to study the underlying pathomechanisms and a well-established tool in order to better understand the disease are colitis models in rodents. Since the concept of the 3Rs was proposed by Russell and Burch, this would include pain medication in animal models of intestinal inflammation as a reduction of suffering. This review argues against pain medication because the administration of pain medication in its current form has an impact on the inflammatory process and the immune response, thus falsifying the results and the reproducibility and therefore leading to misconceptions.

11 October 2021 in Biology
Verified
Journal Article
Open access
PDF file
LGLaura Golusda
Laura Golusda
AKAnja Kühl
Anja Kühl
Britta SiegmundBritta Siegmund
Britta Siegmund
DPDaniela Paclik
Daniela Paclik
Work from the last years indicates that the extracellular matrix (ECM) plays a direct role in various cellular processes, including proliferation, migration and differentiation. Besides homeostatic processes, its regulatory function in inflammation becomes more and more evident. In inflammation, such as inflammatory bowel disease, the ECM composition is constantly remodeled, and this can result in a structuring of fistulizing disease course. Thus, tracking early ECM changes might bear the potential to predict the disease course. In this review, we provide an overview of relevant diagnostic methods, focusing on ECM changes.

5 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
JSJonas Schulte-Schrepping
Jonas Schulte-Schrepping
NRNico Reusch
Nico Reusch
DPDaniela Paclik
Daniela Paclik
KBKevin Baßler
Kevin Baßler
SSStephan Schlickeiser
Stephan Schlickeiser
D(Deutsche COVID-19 OMICS Initiative (DeCOI)
Deutsche COVID-19 OMICS Initiative (DeCOI)
‘Severe Acute Respiratory Syndrome - Coronavirus-2’ (SARS-CoV-2) infection causes Coronavirus Disease 2019 (COVID-19), a mild to moderate respiratory tract infection in the majority of patients. A subset of patients, however, progresses to severe disease and respiratory failure with acute respiratory distress syndrome (ARDS). Severe COVID-19 has been associated with increased neutrophil counts and dysregulated immune responses. The mechanisms of protective immunity in mild forms and the pathogenesis of dysregulated inflammation in severe courses of COVID-19 remain largely unclear. Here, we combined two single-cell RNA-sequencing technologies and single-cell proteomics in whole blood and peripheral blood mononuclear cells (PBMC) to determine changes in immune cell composition and activation in two independent dual-center patient cohorts (n=46+n=54 COVID-19 samples), each with mild and severe cases of COVID-19. We observed a specific increase of HLA-DR hi CD11c hi inflammatory monocytes that displayed a strong interferon (IFN)-stimulated gene signature in patients with mild COVID-19, which was absent in severe disease. Instead, we found evidence of emergency myelopoiesis, marked by the occurrence of immunosuppressive pre-neutrophils and immature neutrophils and populations of dysfunctional and suppressive mature neutrophils, as well as suppressive HLA-DR to monocytes in severe COVID-19. Our study provides detailed insights into systemic immune response to SARS-CoV-2 infection and it reveals profound alterations in the peripheral myeloid cell compartment associated with severe courses of COVID-19.

1 June 2011 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
DPDaniela Paclik
Daniela Paclik
KLKatrin Lohse
Katrin Lohse
BWBertram Wiedenmann
Bertram Wiedenmann
ADAxel U. Dignass
Axel U. Dignass
ASAndreas Sturm
Andreas Sturm
Daniela Paclik, Katrin Lohse, Bertram Wiedenmann, Axel U. Dignass, Andreas Sturm. Galectin-2 and -4, but not Galectin-1, promote intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism. IBD 14;10:1366-1372.